Atractylenolide I modulates ovarian cancer cell-mediated immunosuppression by blocking MD-2/TLR4 complex-mediated MyD88/NF-κB signaling in vitro
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Atractylenolide I modulates ovarian cancer cell-mediated immunosuppression by blocking MD-2/TLR4 complex-mediated MyD88/NF-κB signaling in vitro ; volume:14 ; number:1 ; day:27 ; month:4 ; year:2016 ; pages:1-12 ; date:12.2016
Journal of translational medicine ; 14, Heft 1 (27.4.2016), 1-12, 12.2016
- Creator
-
Liu, Hong
- Contributor
-
Zhang, Guonan
Huang, Jianming
Ma, Shiqi
Mi, Kun
Cheng, Jia
Zhu, Yi
Zha, Xiao
Huang, Wei
SpringerLink (Online service)
- DOI
-
10.1186/s12967-016-0845-5
- URN
-
urn:nbn:de:1111-201604287008
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Liu, Hong
- Zhang, Guonan
- Huang, Jianming
- Ma, Shiqi
- Mi, Kun
- Cheng, Jia
- Zhu, Yi
- Zha, Xiao
- Huang, Wei
- SpringerLink (Online service)
Other Objects (12)
Species variations in muscle stem cell-mediated immunosuppression on T cells
TLR/MyD88 signaling in B cells suppresses T cell-mediated CNS autoimmunity
Regulatory B cell-mediated immunomodulation controls T cell-mediated protective immunity versus immunopathology
Heme activates TLR4-mediated inflammatory injury via MyD88/TRIF signaling pathway in intracerebral hemorrhage
Tumor-released autophagosomes induces CD4+ T cell-mediated immunosuppression via a TLR2–IL-6 cascade
Cell-mediated immunity : In vitro correlates
Resolution of cell-mediated airways diseases
Mechanisms behind T cell-mediated neuroinflammation
Adenine nucleotide signaling in viral infection and immunoregulation as exemplified by mesenchymal stem cell-mediated immunosuppression
Targeting MDSC-mediated immunosuppression in melanoma
TLR9 agonism differentially impacts human NK cell-mediated direct killing and antibody-dependent cell-mediated cytotoxicity
Biomaterials Facilitating Dendritic Cell‐Mediated Cancer Immunotherapy
Species variations in muscle stem cell-mediated immunosuppression on T cells
TLR/MyD88 signaling in B cells suppresses T cell-mediated CNS autoimmunity
Regulatory B cell-mediated immunomodulation controls T cell-mediated protective immunity versus immunopathology
Heme activates TLR4-mediated inflammatory injury via MyD88/TRIF signaling pathway in intracerebral hemorrhage
Tumor-released autophagosomes induces CD4+ T cell-mediated immunosuppression via a TLR2–IL-6 cascade
Cell-mediated immunity : In vitro correlates
Resolution of cell-mediated airways diseases
Mechanisms behind T cell-mediated neuroinflammation
Adenine nucleotide signaling in viral infection and immunoregulation as exemplified by mesenchymal stem cell-mediated immunosuppression
Targeting MDSC-mediated immunosuppression in melanoma
TLR9 agonism differentially impacts human NK cell-mediated direct killing and antibody-dependent cell-mediated cytotoxicity
Biomaterials Facilitating Dendritic Cell‐Mediated Cancer Immunotherapy
Species variations in muscle stem cell-mediated immunosuppression on T cells
TLR/MyD88 signaling in B cells suppresses T cell-mediated CNS autoimmunity
Regulatory B cell-mediated immunomodulation controls T cell-mediated protective immunity versus immunopathology
Heme activates TLR4-mediated inflammatory injury via MyD88/TRIF signaling pathway in intracerebral hemorrhage
Tumor-released autophagosomes induces CD4+ T cell-mediated immunosuppression via a TLR2–IL-6 cascade
Cell-mediated immunity : In vitro correlates
Resolution of cell-mediated airways diseases
Mechanisms behind T cell-mediated neuroinflammation
Adenine nucleotide signaling in viral infection and immunoregulation as exemplified by mesenchymal stem cell-mediated immunosuppression
Targeting MDSC-mediated immunosuppression in melanoma
TLR9 agonism differentially impacts human NK cell-mediated direct killing and antibody-dependent cell-mediated cytotoxicity